eRoundup for 12/29/11

The Emory University Research Committee (URC) is pleased to announce the call for proposals for the spring 2012 funding cycle of URC, ACTSI and a new category of funding priorities, high risk/high potential (HH) grants. The URC and the Office of the Provost have set aside resources to support highly innovative projects that fall outside of traditional external funding support mechanisms. Proposals are invited from all current, regular full-time faculty throughout Emory University.

This NIH invites applications for R01 awards that will accelerate the translation of promising technologies for single cell analysis from prototype into practice in a wide variety of clinical and research settings. Awards will focus on supporting multidisciplinary teams that apply an integrative, quantitative approach to developing these technologies.

This award supports highly promising beginning scientists in their progress toward independence by encouraging and adequately funding research projects that can bridge the gap between completion of research training and readiness for successful competition as an independent investigator. The focus is research broadly related to cardiovascular function and disease and stroke, or to related clinical, basic science, bioengineering or biotechnology and public health problems, including multidisciplinary efforts. 

The NIH Academic Research Enhancement Award program enables qualified scientists to receive support for small-scale scientific research in the biomedical and behavioral sciences.

The Emory/Georgia Tech Healthcare Innovation Program (HIP), in partnership with the ACTSI, is pleased to invite research seed grant proposals in Healthcare Innovation. The seed grant program will fund multi-investigator, multidisciplinary teams examining healthcare services and clinical effectiveness. Preliminary Study grants and Complete Project grants will be offered. A NEW RFA is available here.

The pilot opportunities focus on seeding collaborative efforts that link primary faculty investigators who are on the medical staff of Children’s Healthcare of Atlanta or are faculty members of the Emory Department of Pediatrics to investigators with related interests including those in other departments at Emory and at other institutions within the State of Georgia.

This FOA invites research grant applications to conduct time-sensitive ancillary studies related to heart, lung, and blood diseases and sleep disorders in conjunction with ongoing clinical trials and other large clinical studies supported by NIH or non-NIH entities.

This FOA issued by the National Institute of Biomedical Imaging and Bioengineering encourages grant applications for Biomedical Technology Resource Centers (BTRC’s) that are funded using the P41 mechanism. BTRC’s conduct research and development on new technologies that are driven by the needs of basic, translational and clinical researchers.

Dr. Stephen Traynelis

The Georgia Tech/Emory Department of Biomedical Engineering (BME) is seeking medical development project ideas from the Atlanta medical/research community for capstone project teams in biomedical engineering. If you have a clinical or surgical oriented idea or "problem," you can work with a team of senior BME students in developing and testing a potential solution. Capstone work can provide valuable background for future project funding submissions and further development activities.

The ACTSI Certificate Program in Translational Research is offering a basic biostatistics course and invites junior faculty members to enroll. This is a spring semester course which meets every Tuesday from 1:00-2:50 p.m. beginning on January 24 until May 1, 2012. Contact Cheryl Sroka.

Applications are currently being accepted for Fall 2012. As part of the Howard Hughes Medical Institute “Med into Grad” Initiative, the Emory Laney Graduate School is now offering a Certificate Program in Translational Research. Applicants must be PhD graduate students in the biomedical sciences and/or biomedical engineering at Emory, Morehouse School of Medicine, and Georgia Tech and with an interest in obtaining training in translational research.

Applications are being accepted for the Master of Science in Clinical Research (MSCR) degree program for classes beginning in August 2012. The Emory MSCR is part of the Research Education, Training & Career Development (RETCD) program of the ACTSI. The MSCR provides didactic and mentored clinical and/or translational research training. The MSCR program is designed for participants who hold a doctorate or equivalent degree (such as physicians including fellows and junior faculty and PhD-level scientists including postdoctoral fellows and junior faculty) and have demonstrated a commitment to a career in clinical investigation that incorporates clinical and/or translational research.

Junior faculty members at the MD and PhD level from a wide variety of disciplines at Emory, Morehouse School of Medicine or Georgia Tech who are committed to an academic career in clinical and/or translational research and who have excellent potential to become an independent clinical investigator are encouraged to apply. The KL2 award provides support for didactic and mentored research training for junior faculty members.

HIPAA regulations will be discussed by Emory’s Director of the Office of Research Compliance Kris West. The workshop will be held from 7:00-7:30 a.m. in room 5012, on the 5th floor of the Winship Cancer Institute.

The K-Club provides an educational forum to assist fellows and faculty. NIH Grant Application Reviews will discuss what happens behind the closed doors of the review process. Pediatric researchers and Pediatric junior faculty and fellows interested in academic research careers should attend. Grants advocate, Stacy Heilman, PhD will lead the session. The meeting will be held from Noon-1:00 p.m.  in Egleston, Classroom 5. Questions?

Healthcare reform is on the horizon, but what does it really mean? Join one of the nation’s foremost healthcare leaders, Steven Lipstein, president and CEO of BJC Healthcare, to discuss exactly what reform will mean to medical professionals, health education, patients and others. This Future Makers lecture will begin at 5:00 p.m. in Emory’s Woodruff Health Sciences Center Auditorium. Questions?

A proven entrepreneur training course designed to help technology/science-based entrepreneurs grow a great idea into a successful business. The course will be given in six full-day sessions over seven weeks at Emory University Main Campus. Please visit TechVenture to apply.

The K-Club provides an educational forum to assist fellows and faculty. How NIH Works will be led by Paul Spearman, MD, Emory’s Vice Chair for Research and Chief Research Officer at Children’s Healthcare of Atlanta. Pediatric researchers and Pediatric junior faculty and fellows interested in academic research careers should attend. The meeting will be held from Noon-1:00 p.m.  in Egleston, Classroom 5-7. Questions?

Emory’s Office for Clinical Research presents Research Matters from 11:30 a.m. until 1:00 p.m. in Emory’s EUH Auditorium, Second Floor. This event offers CME hours. Click here to register.

The event aims to promote interaction and collaboration among scientists, engineers and clinicians in developing nanotechnologies for infectious diseases applications. The all-day symposium will be held in Emory’s Woodruff Health Science Center Administration Building, Auditorium.

The event focuses on improving health through research and training. All translational professionals and academics are invited to converse, discover and explore topics in a three-day meeting.

Modeling and simulation are critical in systematically integrating diverse preclinical information to predict clinical response. In this all-day symposium, guiding principles and specific applications in quantitative translational research will be reviewed.

In a move to re-engineer the process of translating scientific discoveries into new drugs, diagnostics and devices, the NIH has established the National Center for Advancing Translational Sciences (NCATS). NCATS will serve as the nation's hub for catalyzing innovations in translational science. NCATS will strive to identify and overcome hurdles that slow the development of effective treatments and cures. The Clinical & Translational Science Award (CTSA) program (and the ACTSI) will move into NCATS. Tom Insel, MD, the former director of the Yerkes National Primate Research Center, will serve as the Acting Director of NCATS.

Fadlo Khuri, MD, ACTSI investigator, deputy director of the Winship Cancer Institute, professor and chairman of the Department of Hematology and Medical Oncology at Emory University School of Medicine and editor-in-chief of Cancer, a journal of the American Cancer Society.

ABCNews.com | ABC ousted Penn State football coach Joe Paterno's 'treatable' lung cancer: What it means
November 18, 2011

WABE | Emory Researcher discusses prevention and treatment of lung cancer
August 8, 2011

www.CTSAcentral.org

The CTSA Progress Report 2009-2011 is now live on the NCRR website and features ACTSI’s Linda Cendales.

The Clinical Research Forum announces its inaugural Top 10 Clinical Research Achievement Awards honoring outstanding accomplishments in clinical research. This national competition seeks to identify major advances resulting from the nation's investment in research to benefit the health and welfare of its citizens.

Clinical researchers are investigating strategies to tailor disease treatments to each patient. This symposium reviewed state-of-the-art research, translational medical research data and new technologies to make personalized medicine a reality.